Independent reference. Not affiliated with, endorsed by, or speaking for the U.S. Food and Drug Administration.
FDA Medication Tracker

← All approvals · Heart & blood · 2024

Flyrcado (flurpiridaz F 18)

The FDA approved Flyrcado (flurpiridaz F 18) on September 27, 2024 A radioactive diagnostic drug to evaluate for myocardial ischemia and infarction.
Brand name
Flyrcado
Generic name
flurpiridaz F 18
FDA approval date
September 27, 2024
Approved use (FDA wording)
A radioactive diagnostic drug to evaluate for myocardial ischemia and infarction
Category on this site
Heart & blood

Official sources

Facts only. This site lists what the FDA has approved and what the FDA says each drug is approved for, quoted or closely paraphrased from FDA and openFDA records. It gives no medical advice, no dosing, and no comparisons, and it says nothing about whether a drug is right for anyone. Talk to a licensed clinician about any medication. Records can lag or contain errors; the FDA's own pages are authoritative.